期刊文献+

肺炎球菌荚膜多糖去氧胆酸钠残留量测定方法的优化及验证

Optimization and verification of determination method for residual deoxysodium cholate content in pneumococcal polysaccharide
原文传递
导出
摘要 目的 优化肺炎球菌荚膜多糖中去氧胆酸钠残留量的检测方法,并进行验证。方法 采用《中国药典》三部(2010版)甲型肝炎灭活疫苗制造与检定规程附录Ⅰ中去氧胆酸钠残留量测定法,对肺炎球菌荚膜多糖原液中去氧胆酸钠残留量测定方法进行适用性确认;比较对照品在70℃水浴不同时间(20、40、60、120 min)及80℃水浴30 min的吸光度值,确定最佳反应温度及时间;验证优化后方法的线性、重复性及准确度。结果2批肺炎球菌荚膜多糖原液70℃水浴20 min后检测去氧胆酸钠残留量,回收率在8.6%~240.8%之间,适用性不合格;优化后的反应条件为80℃水浴30 min。去氧胆酸钠浓度在10~80μg/ml范围内,与A值呈良好的线性关系,R2〈0.99;3批去氧胆酸钠对照品溶液的重复性测定结果的CV值均小于8%;23种肺炎球菌荚膜多糖原液分别添加低、中、高浓度的去氧胆酸钠对照品溶液回收率在80%~120%之间。结论 优化后的肺炎球菌荚膜多糖去氧胆酸钠残留量测定方法操作简单,线性好,结果准确,重复性好,可用于肺炎球菌荚膜多糖去氧胆酸钠残留量的检测。 Objective To optimize the determination method for residual deoxysodium cholate content in pneumococcal polysaccharide. Methods The determination method for residual deoxysodium cholate content in bulk of pneumococcal polysaccharide was verified for suitability by the method in Chinese Pharmacopoeia (Volume Ⅲ, 2010 edition). The absorbance of reference after incubation in 70 ℃ water bath for 20, 40, 60 and 120 rain and in 80 ℃ water bath for 30 min were determined, based on which the reaction temperature and time were optimized. The optimized method was verified for linearity, reproducibility and accuracy. Results The residual deoxysodium cholate content in two batches of bulks of pneumococcal polysaccharide after incubation in 70 ℃ water bath for 20 rain were determined, and the result showed recoveries of 8. 6% -240. 8%, indicating that the suitability was unqualified. The condition for reaction was optimized as incubation in 80 ℃ water bath for 30 min. The deoxysodium cholate contents at a range of 10 - 80 μg/ml showed good linearity with the absorbances, with a R2 value of more than 0. 99. The CVs of determination results of three batches of references in reproducibility test were less than 8%. The recovery rates of deoxysodium cholate at low, moderate and high concentrations, added to 23 kinds of bulks of pneumococcal polysaccharide, were 80% - 120%. Conclusion The optimized method was simple, which showed good linearity, accuracy and reproducibility, and might be used for determination of residual deoxysodium cholate content in pneumococcal polysaccharide.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第6期843-847,共5页 Chinese Journal of Biologicals
关键词 肺炎球菌 荚膜多糖 去氧胆酸钠 含量测定 Pneumococcus Capsular polysaccharide Deoxysodium cholate Content determination
  • 相关文献

参考文献11

  • 1蒲江,杜琳.肺炎链球菌及其疫苗研究[J].临床肺科杂志,2010,15(3):381-382. 被引量:8
  • 2WHO.Recommendations to assure the quality,safety and efficacy of pneumococcal conjugate vaccines[C].60th meeting of the WHO Expert Committee on Biological Standardization,Geneva,2009.
  • 3杨耀,栗克喜,宋绍忠,张云,江山,谢全海,兰芳,黄剑,黎云东,李凤祥,袁曾麟,郭淑英,石继春,何莉.23价肺炎球菌多糖疫苗临床试验[J].预防医学情报杂志,2007,23(4):390-391. 被引量:34
  • 4Butler JC,Breiman RF,Campbell JF,et al.Pneumococcal polysaccharide vaccine efficacy.An evaluation of current recommendations[J].JAMA,1993,270(15):1826-1831.
  • 5Leophonte P,Neukrich F.Anti-pneumococci vaccination:role and indications in the prevention of community acquired infections of the lower respiratory tract[J].Med Mal Infect,2000,31(4):181-194.
  • 6Jackson LA,Benson P,Sneller VP,et al.Safety of revaccination with pneumococcal polysaccharide vaccine[J].JAMA,1999,281(3):243-248.
  • 7Gable CB,Holzer SS,Engelhart L,et al.Pneumococcal vaccine.Efficacy and associated cost savings[J].JAMA,1990,264(22):2910-2915.
  • 8王建国,江黎丽,惠飞,杨薇薇,吕慧,孙巧花.脱氧胆酸钠与支撑磷脂双层膜作用的电化学研究[J].化学学报,2007,65(3):239-245. 被引量:14
  • 9周易.关于回收率的计算公式[J].分析化学,1985,13(10):82.
  • 10国家食品药品监督管理局药品审评中心.有关物质分析方法验证的可接受标准简介[S].2006-02-08.

二级参考文献53

  • 1佟月娟,姚开虎,俞桑洁,李燕,杨永弘.上呼吸道感染患儿肺炎链球菌血清群/型及耐药分析[J].中国计划免疫,2007,13(1):75-78. 被引量:5
  • 2张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 3Bernard F. Epidemiology of invasive pneumococcal disease in Europe. Current Therapeutic research ,2002,63 (supplA) : A32A9.
  • 4Pal R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol, 2006,44 : 124 - 131.
  • 5Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneu2mococcal serogroups cause the most invasive disease : implications for conjugate vaccine formulation and use, part Ⅰ. Clin Infect Dis, 2000,30 : 100 -121.
  • 6Yang F, et al. Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumaniae isolated from Shanghai, China. Int. J. Antimicrob. Agents ( 2008 ), doi : 10. 1016/j. ijantimicag. 2008. 05. 004.
  • 7Margaret Ip, E. Anthony S. Nelson, Edmund S. C. Cheuk, et al. Serotype Distribution and Antimierobial Susceptibilities of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children Hospitalized for Acute Respiratory Illnesses in Hong Kong. Clinical Microbiology,2007,15(6) :1969 - 1971.
  • 8Liu YD, Wang H, Chen MJ, et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagnostic Microbiology and Infectious Disease,2008,61:256 -263.
  • 9Austrian R. Pneumococcal otitis media and pneumococcal Vaccines , a historical perspective. Vaccine,2000,19 ( Suppl 1 ) : S71277.
  • 10Lee LH, Lee C J, Fraseh CE. Development and evaluation of pneumococcal eonjugate vaccine: elinieal trials and control tests. Crit Rev Mierobiol,2002,28 ( 1 ) :27 - 41.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部